157 related articles for article (PubMed ID: 27484289)
1. MicroRNA-491 regulates the proliferation and apoptosis of CD8(+) T cells.
Yu T; Zuo QF; Gong L; Wang LN; Zou QM; Xiao B
Sci Rep; 2016 Aug; 6():30923. PubMed ID: 27484289
[TBL] [Abstract][Full Text] [Related]
2. Transgene-derived overexpression of miR-17-92 in CD8+ T-cells confers enhanced cytotoxic activity.
Kosaka A; Ohkuri T; Ikeura M; Kohanbash G; Okada H
Biochem Biophys Res Commun; 2015 Mar; 458(3):549-554. PubMed ID: 25677619
[TBL] [Abstract][Full Text] [Related]
3. The TGF-β-inducible miR-23a cluster attenuates IFN-γ levels and antigen-specific cytotoxicity in human CD8⁺ T cells.
Chandran PA; Keller A; Weinmann L; Seida AA; Braun M; Andreev K; Fischer B; Horn E; Schwinn S; Junker M; Houben R; Dombrowski Y; Dietl J; Finotto S; Wölfl M; Meister G; Wischhusen J
J Leukoc Biol; 2014 Oct; 96(4):633-45. PubMed ID: 25030422
[TBL] [Abstract][Full Text] [Related]
4. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
[TBL] [Abstract][Full Text] [Related]
5. Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease.
Wong M; La Cava A; Singh RP; Hahn BH
J Immunol; 2010 Dec; 185(11):6563-71. PubMed ID: 21041733
[TBL] [Abstract][Full Text] [Related]
6. The siRNA cocktail targeting interleukin 10 receptor and transforming growth factor-β receptor on dendritic cells potentiates tumour antigen-specific CD8(+) T cell immunity.
Ahn YH; Hong SO; Kim JH; Noh KH; Song KH; Lee YH; Jeon JH; Kim DW; Seo JH; Kim TW
Clin Exp Immunol; 2015 Jul; 181(1):164-78. PubMed ID: 25753156
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs 15A and 16-1 Activate Signaling Pathways That Mediate Chemotaxis of Immune Regulatory B cells to Colorectal Tumors.
Liu R; Lu Z; Gu J; Liu J; Huang E; Liu X; Wang L; Yang J; Deng Y; Qian J; Luo F; Wang Z; Zhang H; Jiang X; Zhang D; Qian J; Liu G; Zhu H; Qian Y; Liu Z; Chu Y
Gastroenterology; 2018 Feb; 154(3):637-651.e7. PubMed ID: 29031499
[TBL] [Abstract][Full Text] [Related]
8. Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells.
Zhang Q; Jang TL; Yang X; Park I; Meyer RE; Kundu S; Pins M; Javonovic B; Kuzel T; Kim SJ; Van Parijs L; Smith N; Wong L; Greenberg NM; Guo Y; Lee C
Prostate; 2006 Feb; 66(3):235-47. PubMed ID: 16173028
[TBL] [Abstract][Full Text] [Related]
9. MiR-15a/16 deficiency enhances anti-tumor immunity of glioma-infiltrating CD8+ T cells through targeting mTOR.
Yang J; Liu R; Deng Y; Qian J; Lu Z; Wang Y; Zhang D; Luo F; Chu Y
Int J Cancer; 2017 Nov; 141(10):2082-2092. PubMed ID: 28758198
[TBL] [Abstract][Full Text] [Related]
10. miR-625-3p is upregulated in CD8+ T cells during early immune reconstitution after allogeneic stem cell transplantation.
Verma K; Jyotsana N; Buenting I; Luther S; Pfanne A; Thum T; Ganser A; Heuser M; Weissinger EM; Hambach L
PLoS One; 2017; 12(8):e0183828. PubMed ID: 28854245
[TBL] [Abstract][Full Text] [Related]
11. Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells.
Rizzo A; De Mare V; Rocchi C; Stolfi C; Colantoni A; Neurath MF; Macdonald TT; Pallone F; Monteleone G; Fantini MC
Carcinogenesis; 2014 Jul; 35(7):1536-46. PubMed ID: 24480808
[TBL] [Abstract][Full Text] [Related]
12. IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer.
Abiko K; Matsumura N; Hamanishi J; Horikawa N; Murakami R; Yamaguchi K; Yoshioka Y; Baba T; Konishi I; Mandai M
Br J Cancer; 2015 Apr; 112(9):1501-9. PubMed ID: 25867264
[TBL] [Abstract][Full Text] [Related]
13. Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer.
Colangelo T; Polcaro G; Ziccardi P; Pucci B; Muccillo L; Galgani M; Fucci A; Milone MR; Budillon A; Santopaolo M; Votino C; Pancione M; Piepoli A; Mazzoccoli G; Binaschi M; Bigioni M; Maggi CA; Fassan M; Laudanna C; Matarese G; Sabatino L; Colantuoni V
Cell Death Dis; 2016 Feb; 7(2):e2120. PubMed ID: 26913609
[TBL] [Abstract][Full Text] [Related]
14. miR-155 Controls Lymphoproliferation in LAT Mutant Mice by Restraining T-Cell Apoptosis via SHIP-1/mTOR and PAK1/FOXO3/BIM Pathways.
Rouquette-Jazdanian AK; Kortum RL; Li W; Merrill RK; Nguyen PH; Samelson LE; Sommers CL
PLoS One; 2015; 10(6):e0131823. PubMed ID: 26121028
[TBL] [Abstract][Full Text] [Related]
15. Altered T-Cell Balance in Lymphoid Organs of a Mouse Model of Colorectal Cancer.
Tanner SM; Daft JG; Hill SA; Martin CA; Lorenz RG
J Histochem Cytochem; 2016 Dec; 64(12):753-767. PubMed ID: 27798287
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of inflammatory microRNAs by Ig-like transcript 3 is essential for the differentiation of human CD8(+) T suppressor cells.
Chang CC; Zhang QY; Liu Z; Clynes RA; Suciu-Foca N; Vlad G
J Immunol; 2012 Apr; 188(7):3042-52. PubMed ID: 22387553
[TBL] [Abstract][Full Text] [Related]
17. Tumour-mediated TRAIL-Receptor expression indicates effective apoptotic depletion of infiltrating CD8+ immune cells in clinical colorectal cancer.
Grimm M; Kim M; Rosenwald A; von Raden BH; Tsaur I; Meier E; Heemann U; Germer CT; Gasser M; Waaga-Gasser AM
Eur J Cancer; 2010 Aug; 46(12):2314-23. PubMed ID: 20580220
[TBL] [Abstract][Full Text] [Related]
18. miR-150 Regulates Memory CD8 T Cell Differentiation via c-Myb.
Chen Z; Stelekati E; Kurachi M; Yu S; Cai Z; Manne S; Khan O; Yang X; Wherry EJ
Cell Rep; 2017 Sep; 20(11):2584-2597. PubMed ID: 28903040
[TBL] [Abstract][Full Text] [Related]
19. Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.
Zhang Q; Yang X; Pins M; Javonovic B; Kuzel T; Kim SJ; Parijs LV; Greenberg NM; Liu V; Guo Y; Lee C
Cancer Res; 2005 Mar; 65(5):1761-9. PubMed ID: 15753372
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for human renal cell carcinoma by adoptive transfer of autologous transforming growth factor beta-insensitive CD8+ T cells.
Wang L; Wen W; Yuan J; Helfand B; Li Y; Shi C; Tian F; Zheng J; Wang F; Chen L; Liang L; Zhou L; Lee C; Chen Z; Guo Y; Wang H; Zhang Q; Qin W
Clin Cancer Res; 2010 Jan; 16(1):164-73. PubMed ID: 20028741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
